Answers are grounded in this paper and cite their sources.
Effective infectious disease response requires region-specific guidance, because the contact structures that drive local transmission and shape intervention effects vary from community to community. Agent-based models (ABMs) represent these structures and the individual heterogeneity underlying them, which makes them well suited to local intervention analysis, but they are computationally expensive and fitting their parameters to data is difficult. We present a framework that avoids direct ABM fitting by using a surrogate ordinary differential equation (ODE) model as an intermediary between routine surveillance data and a mechanistically rich ABM. Such data rarely identify ABM parameters uniquely: many combinations of transmissibility, severity, and reporting can reproduce the same observed trajectories. Rather than committing to a single best-fit configuration, the framework retains the full set of ABM parameter combinations consistent with observed case and hospitalization data and propagates this uncertainty into every downstream intervention estimate. We apply the framework to COVID-19 in nine demographically distinct Michigan counties as an illustrative case study. For each county, we recover the ABM parameter regions consistent with local case and hospitalization data, verify that the calibrated model reproduces the observed trajectories, and then evaluate four non-pharmaceutical interventions across those regions. We find that the ranking and robustness of the interventions differ substantially across counties, and that simple demographic predictors do not reliably predict which will succeed. We use intervention implementation assumptions (e.g., for compliance and efficacy) drawn from COVID-19 literature, but the framework is general and can take user-specified assumptions and show what conclusions they would lead to. By coupling mechanistic ABMs with explicit uncertainty propagation, the approach provides a generic route to local, uncertainty-aware intervention analysis for COVID-19, influenza, measles, and other pathogens.
No takes yet. Share an insight, caveat, or question.
Dudley et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: